Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced GI Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)UnknownNCT03474861
What this trial is testing

Safety and Efficacy of an Anticancer Medication Combined With Immune Cells in Subjects With Gastrointestinal Cancer

Who this might be right for
Gastrointestinal Cancer
Hangzhou Converd Co., Ltd. 15
Testing effectiveness (Phase 2)WithdrawnNCT02344810
What this trial is testing

C-Met Inhibitor AMG 337, Oxaliplatin, Leucovorin Calcium, and Fluorouracil in Treating Patients With Advanced Stomach or Esophageal Cancer

Who this might be right for
Adenocarcinoma of the EsophagusAdenocarcinoma of the Gastroesophageal JunctionDiffuse Adenocarcinoma of the Stomach+11 more
Eastern Cooperative Oncology Group
Large-scale testing (Phase 3)Ended earlyNCT00387348
What this trial is testing

Escitalopram in Treating Depression in Patients With Advanced Lung or Gastrointestinal Cancer

Who this might be right for
Colorectal CancerDepressionEsophageal Cancer+7 more
Massachusetts General Hospital 24
Early research (Phase 1)Ended earlyNCT03449030
What this trial is testing

TAK-164 in Participants With Advanced Gastrointestinal (GI) Cancer Expressing Guanylyl Cyclase C (GCC)

Who this might be right for
Gastrointestinal Neoplasms; Esophageal, Stomach, Pancreas, Colon Neoplasms; Malignant Tumors of Digestive Organ; Advanced Gastrointestinal Malignancies
Millennium Pharmaceuticals, Inc. 31
Not applicableUnknownNCT05427227
What this trial is testing

Prospectively Predict the Efficacy and Explore the Mechanism of Treatment of Gastrointestinal Tumors Based on Peripheral Multi-omics Liquid Biopsy

Who this might be right for
Advanced or Late Stage Gastrointestinal Cancer
Peking University 500
Testing effectiveness (Phase 2)Study completedNCT01465802
What this trial is testing

Study Of Dacomitinib (PF-00299804) In Advanced NSCLC Patients (Post Chemo Or Select First Line) To Evaluate Prophylactic Intervention On Derm And GI AEs And PRO

Who this might be right for
Non Small Cell Lung Cancer (NSCLC)
Pfizer 236
Testing effectiveness (Phase 2)Study completedNCT05001347
What this trial is testing

A Clinical Study of TJ004309 With Atezolizumab (TECENTRIQ®) in Patients With Ovarian Cancer and Selected Solid Tumors

Who this might be right for
Ovarian CancerHead and Neck CancerNon Small Cell Lung Cancer+3 more
I-Mab Biopharma US Limited 25
Early research (Phase 1)Study completedNCT01640665
What this trial is testing

Pilot Study of Sorafenib and Bi-weekly Capecitabine in Patients With Advanced Breast and Gastrointestinal Tumors

Who this might be right for
Metastatic Breast CancerGastrointestinal Tumors
Yale University 24
Early research (Phase 1)Ended earlyNCT02268825
What this trial is testing

Phase I Study MK-3475 With Chemotherapy in Patients With Advanced GI Cancers

Who this might be right for
Advanced GI Cancer
University of Utah 39
Not applicableWithdrawnNCT05917990
What this trial is testing

Dyadic Text-Messaging Micro-Intervention

Who this might be right for
Advanced CancerGastrointestinal Cancer
Duke University
Not applicableLooking for participantsNCT06532877
What this trial is testing

Telephone Support in Advanced Gastrointestinal Cancer

Who this might be right for
Gastrointestinal Neoplasm MalignantCaregiver Burden
Indiana University 488
Not applicableStudy completedNCT01833637
What this trial is testing

Electronic Patient Reported Symptom Assessment

Who this might be right for
Gynecologic CancerBreast CancerThoracic Cancer+1 more
Northwestern University 6
Early research (Phase 1)Study completedNCT00397384
What this trial is testing

Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer

Who this might be right for
Adenocarcinoma of the ColonAdenocarcinoma of the RectumAdvanced Adult Primary Liver Cancer+64 more
National Cancer Institute (NCI) 43
Testing effectiveness (Phase 2)Study completedNCT00089960
What this trial is testing

Study of AMG 706 in Subjects With Advanced Gastrointestinal Stromal Tumors (GISTs)

Who this might be right for
Gastrointestinal Cancer
Amgen 138
Not applicableLooking for participantsNCT06626269
What this trial is testing

Identification of Innovative Biomarkers Related to the Immune System or Tumor Microenvironment to Promote the Efficacy of Immunotherapies

Who this might be right for
Advanced Digestive CancerAdvanced Gynecologic Cancer
Centre Hospitalier Universitaire de Besancon 700
Early research (Phase 1)Study completedNCT02333188
What this trial is testing

Genetic Analysis-Guided Dosing of FOLFIRABRAX in Treating Patients With Advanced Gastrointestinal Cancer

Who this might be right for
Adenocarcinoma of Unknown PrimaryAdult CholangiocarcinomaGallbladder Carcinoma+14 more
University of Chicago 50
Large-scale testing (Phase 3)Looking for participantsNCT06028737
What this trial is testing

Total Neoadjuvant FLOT Chemotherapy in Locally Advanced Gastric and Gastroesophageal Junction Cancer

Who this might be right for
Gastric CancerStomach CancerGastroEsophageal Cancer+13 more
Ukrainian Society of Clinical Oncology 150
Early research (Phase 1)Ended earlyNCT00300027
What this trial is testing

Study of BMS-582664 in Combination With Either FOLFIRI or FOLFOX for Gastrointestinal (GI) Malignancies

Who this might be right for
Gastrointestinal Neoplasms
Bristol-Myers Squibb 50
Early research (Phase 1)Study completedNCT01420874
What this trial is testing

Anti-CD3 x Anti-Erbitux® Armed Activated T Cells (Phase Ib) for Gastrointestinal (GI Cancer)

Who this might be right for
Colorectal CancerCancer of PancreasPancreatic Neoplasm+5 more
Barbara Ann Karmanos Cancer Institute 15
Early research (Phase 1)Looking for participantsNCT06414733
What this trial is testing

HER-2 B Cell Peptide Vaccine

Who this might be right for
Metastatic Breast CancerHER2-positive Breast CancerEGFR Overexpression+2 more
Pravin T.P Kaumaya 42
Next Page